Florida Financial Advisors LLC Acquires Shares of 9,989 Cardinal Health, Inc. $CAH

Florida Financial Advisors LLC bought a new position in Cardinal Health, Inc. (NYSE:CAH) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor bought 9,989 shares of the company’s stock, valued at approximately $1,568,000.

A number of other large investors also recently bought and sold shares of the business. Integrated Wealth Concepts LLC lifted its holdings in shares of Cardinal Health by 6.9% during the first quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock valued at $601,000 after purchasing an additional 280 shares in the last quarter. Jones Financial Companies Lllp lifted its stake in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares during the period. CWM LLC boosted its holdings in shares of Cardinal Health by 6.3% during the 2nd quarter. CWM LLC now owns 13,135 shares of the company’s stock valued at $2,207,000 after acquiring an additional 774 shares during the last quarter. Sequoia Financial Advisors LLC raised its holdings in shares of Cardinal Health by 11.4% during the second quarter. Sequoia Financial Advisors LLC now owns 8,946 shares of the company’s stock valued at $1,503,000 after purchasing an additional 916 shares during the last quarter. Finally, Moran Wealth Management LLC bought a new position in Cardinal Health during the second quarter valued at approximately $229,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Price Performance

Shares of NYSE:CAH opened at $220.72 on Friday. The company has a market capitalization of $51.94 billion, a P/E ratio of 31.76, a P/E/G ratio of 1.39 and a beta of 0.64. Cardinal Health, Inc. has a 1-year low of $120.72 and a 1-year high of $230.81. The firm’s 50 day simple moving average is $208.84 and its two-hundred day simple moving average is $182.20.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, February 5th. The company reported $2.63 EPS for the quarter, beating the consensus estimate of $2.31 by $0.32. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. The firm had revenue of $65.63 billion for the quarter, compared to the consensus estimate of $64.88 billion. During the same period last year, the firm earned $1.93 EPS. The company’s revenue was up 18.8% on a year-over-year basis. On average, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st will be paid a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Wednesday, April 1st. Cardinal Health’s dividend payout ratio (DPR) is 29.35%.

Key Stories Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Recent quarterly results and underlying strength — Cardinal reported a Q4 EPS beat and revenue above expectations, with revenue up ~19% year-over-year, which analysts cite as supporting the stock’s upside. Cardinal Health’s (NYSE:CAH) Solid Earnings Are Supported By Other Strong Factors
• Positive Sentiment: Dividend confirmed — the Board approved a quarterly dividend of $0.5107 per share (payable Apr 15; record Apr 1). The cash return reinforces income appeal and signals confidence in cash flow. Cardinal Health Board of Directors Approves Quarterly Dividend
• Positive Sentiment: Analyst lift — JPMorgan raised its price target to $243, providing a tangible upside anchor for investors and helping sentiment. JPMorgan Chase Increases Cardinal Health Price Target
• Positive Sentiment: Zacks momentum & valuation coverage — CAH was added to Zacks’ Rank #1 momentum list and several Zacks pieces highlight undervaluation and a favorable long-term value case, which can attract momentum and value investors. Best Momentum Stock to Buy for February 13th Are Investors Undervaluing Cardinal Health?
• Neutral Sentiment: Kalkine notes logistics/reliability improvements on the NYSE composite — operational reliability updates are constructive but are incremental near-term drivers. Cardinal Health Boosts Logistics Reliability
• Neutral Sentiment: Analyst Q&A from the earnings call — the transcript highlights management’s priorities and risk items; useful for longer-term fundamental assessment but not an immediate catalyst. The 5 Most Interesting Analyst Questions From Cardinal Health’s Q4 Earnings Call

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. Jefferies Financial Group upped their price objective on Cardinal Health from $220.00 to $270.00 and gave the company a “buy” rating in a research report on Thursday, January 22nd. Morgan Stanley set a $255.00 target price on Cardinal Health in a research report on Friday, February 6th. Evercore reiterated an “outperform” rating and issued a $260.00 price objective on shares of Cardinal Health in a research note on Thursday, February 5th. Finally, UBS Group set a $260.00 target price on shares of Cardinal Health and gave the company a “buy” rating in a research report on Friday, February 6th. Fifteen equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $245.19.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.